Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium

Glucocorticoids are amongst the most used drugs to treat retinal diseases of various origins. Yet, the transcriptional regulations induced by glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation in retinal pigment epithelium cells (RPE) that form the outer blood–retina barrier...

Full description

Bibliographic Details
Main Authors: Jérémie Canonica, Min Zhao, Tatiana Favez, Emmanuelle Gelizé, Laurent Jonet, Laura Kowalczuk, Justine Guegan, Damien Le Menuet, Say Viengchareun, Marc Lombès, Eric Pussard, Yvan Arsenijevic, Francine Behar-Cohen
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
eye
Online Access:https://www.mdpi.com/1422-0067/22/17/9618
id doaj-3eaa15dd4893453a9f19eb65f7cbc9d9
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jérémie Canonica
Min Zhao
Tatiana Favez
Emmanuelle Gelizé
Laurent Jonet
Laura Kowalczuk
Justine Guegan
Damien Le Menuet
Say Viengchareun
Marc Lombès
Eric Pussard
Yvan Arsenijevic
Francine Behar-Cohen
spellingShingle Jérémie Canonica
Min Zhao
Tatiana Favez
Emmanuelle Gelizé
Laurent Jonet
Laura Kowalczuk
Justine Guegan
Damien Le Menuet
Say Viengchareun
Marc Lombès
Eric Pussard
Yvan Arsenijevic
Francine Behar-Cohen
Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium
International Journal of Molecular Sciences
retina
eye
corticoids
retinal pigment epithelium
mineralocorticoid
transcriptional regulation
author_facet Jérémie Canonica
Min Zhao
Tatiana Favez
Emmanuelle Gelizé
Laurent Jonet
Laura Kowalczuk
Justine Guegan
Damien Le Menuet
Say Viengchareun
Marc Lombès
Eric Pussard
Yvan Arsenijevic
Francine Behar-Cohen
author_sort Jérémie Canonica
title Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium
title_short Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium
title_full Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium
title_fullStr Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium
title_full_unstemmed Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium
title_sort pathogenic effects of mineralocorticoid pathway activation in retinal pigment epithelium
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-09-01
description Glucocorticoids are amongst the most used drugs to treat retinal diseases of various origins. Yet, the transcriptional regulations induced by glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation in retinal pigment epithelium cells (RPE) that form the outer blood–retina barrier are unknown. Levels of endogenous corticoids, ligands for MR and GR, were measured in human ocular media. Human RPE cells derived from induced pluripotent stem cells (iRPE) were used to analyze the pan-transcriptional regulations induced by aldosterone—an MR-specific agonist, or cortisol or cortisol + RU486—a GR antagonist. The retinal phenotype of transgenic mice that overexpress the human MR (P1.hMR) was analyzed. In the human eye, the main ligand for GR and MR is cortisol. The iRPE cells express functional GR and MR. The subset of genes regulated by aldosterone and by cortisol + RU-486, and not by cortisol alone, mimics an imbalance toward MR activation. They are involved in extracellular matrix remodeling (<i>CNN1</i>, <i>MGP</i>, <i>AMTN)</i>, epithelial–mesenchymal transition, RPE cell proliferation and migration (<i>ITGB3</i>, <i>PLAUR</i> and <i>FOSL1</i>) and immune balance (<i>TNFSF18</i> and <i>PTX3</i>). The P1.hMR mice showed choroidal vasodilation, focal alteration of the RPE/choroid interface and migration of RPE cells together with RPE barrier function alteration, similar to human retinal diseases within the pachychoroid spectrum. RPE is a corticosteroid-sensitive epithelium. MR pathway activation in the RPE regulates genes involved in barrier function, extracellular matrix, neural regulation and epithelial differentiation, which could contribute to retinal pathology.
topic retina
eye
corticoids
retinal pigment epithelium
mineralocorticoid
transcriptional regulation
url https://www.mdpi.com/1422-0067/22/17/9618
work_keys_str_mv AT jeremiecanonica pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT minzhao pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT tatianafavez pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT emmanuellegelize pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT laurentjonet pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT laurakowalczuk pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT justineguegan pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT damienlemenuet pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT sayviengchareun pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT marclombes pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT ericpussard pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT yvanarsenijevic pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
AT francinebeharcohen pathogeniceffectsofmineralocorticoidpathwayactivationinretinalpigmentepithelium
_version_ 1717760046586134528
spelling doaj-3eaa15dd4893453a9f19eb65f7cbc9d92021-09-09T13:48:53ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-09-01229618961810.3390/ijms22179618Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment EpitheliumJérémie Canonica0Min Zhao1Tatiana Favez2Emmanuelle Gelizé3Laurent Jonet4Laura Kowalczuk5Justine Guegan6Damien Le Menuet7Say Viengchareun8Marc Lombès9Eric Pussard10Yvan Arsenijevic11Francine Behar-Cohen12Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, From Physiopathology of Retinal Diseases to Clinical Advances, 15 rue de l’Ecole de Médecine, 75006 Paris, FranceCentre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, From Physiopathology of Retinal Diseases to Clinical Advances, 15 rue de l’Ecole de Médecine, 75006 Paris, FranceDepartment of Ophthalmology, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, 1004 Lausanne, SwitzerlandCentre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, From Physiopathology of Retinal Diseases to Clinical Advances, 15 rue de l’Ecole de Médecine, 75006 Paris, FranceCentre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, From Physiopathology of Retinal Diseases to Clinical Advances, 15 rue de l’Ecole de Médecine, 75006 Paris, FranceDepartment of Ophthalmology, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, 1004 Lausanne, SwitzerlandInstitut du Cerveau, ICM, iCONICS, Hôpital de la Pitié-Salpêtrière, 75013 Paris, FrancePhysiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, FrancePhysiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, FrancePhysiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, FrancePhysiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, FranceDepartment of Ophthalmology, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, 1004 Lausanne, SwitzerlandCentre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, From Physiopathology of Retinal Diseases to Clinical Advances, 15 rue de l’Ecole de Médecine, 75006 Paris, FranceGlucocorticoids are amongst the most used drugs to treat retinal diseases of various origins. Yet, the transcriptional regulations induced by glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation in retinal pigment epithelium cells (RPE) that form the outer blood–retina barrier are unknown. Levels of endogenous corticoids, ligands for MR and GR, were measured in human ocular media. Human RPE cells derived from induced pluripotent stem cells (iRPE) were used to analyze the pan-transcriptional regulations induced by aldosterone—an MR-specific agonist, or cortisol or cortisol + RU486—a GR antagonist. The retinal phenotype of transgenic mice that overexpress the human MR (P1.hMR) was analyzed. In the human eye, the main ligand for GR and MR is cortisol. The iRPE cells express functional GR and MR. The subset of genes regulated by aldosterone and by cortisol + RU-486, and not by cortisol alone, mimics an imbalance toward MR activation. They are involved in extracellular matrix remodeling (<i>CNN1</i>, <i>MGP</i>, <i>AMTN)</i>, epithelial–mesenchymal transition, RPE cell proliferation and migration (<i>ITGB3</i>, <i>PLAUR</i> and <i>FOSL1</i>) and immune balance (<i>TNFSF18</i> and <i>PTX3</i>). The P1.hMR mice showed choroidal vasodilation, focal alteration of the RPE/choroid interface and migration of RPE cells together with RPE barrier function alteration, similar to human retinal diseases within the pachychoroid spectrum. RPE is a corticosteroid-sensitive epithelium. MR pathway activation in the RPE regulates genes involved in barrier function, extracellular matrix, neural regulation and epithelial differentiation, which could contribute to retinal pathology.https://www.mdpi.com/1422-0067/22/17/9618retinaeyecorticoidsretinal pigment epitheliummineralocorticoidtranscriptional regulation